CoChat

Iron sucrose augments homocysteine-induced endothelial dysfunction in normal subjects

Open access
Zheng, H., Huang, X., Zhang, Q., Katz, S.D. · 2006 · Kidney International

The DOI matches its Crossref record; 62 of the 64 references it cites were found in a registry or an index.

Abstract

Intravenous iron is commonly used in conjunction with erythropoietic agents to treat anemia in patients with chronic kidney disease. Iron has been proposed to promote oxidative stress and endothelial dysfunction in vascular tissues. We studied the acute effects of intravenous iron sucrose on homocysteine-induced endothelial dysfunction in the brachial artery of normal human subjects. In all, 40 healthy subjects received intravenous iron sucrose 100 mg or placebo over 30 min immediately before ingestion of 100 mg/kg of oral methionine in a double-blind, randomized study. Flow- and nitroglycerin-mediated dilation in the brachial artery, serum markers of iron stores, and homocysteine and nitrotyrosine levels were measured before and after study drug administration. Intravenous iron significantly increased transferrin saturation and non-transferrin-bound iron (NTBI) when compared with placebo. Flow-mediated dilation significantly decreased from baseline 1 h after administration of iron sucrose when compared with placebo (from 6.66+/-0.47 to 1.93+/-0.35% after iron sucrose vs from 6.00+/-0.40 to 5.61+/-0.46% after placebo, P<0.001), but did not differ between groups at 4 h (1.10+/-0.39 vs 1.33+/-0.51%). Nitroglycerin-mediated vasodilation, and homocysteine and 3-nitrotyrosine levels did not differ after administration of iron sucrose and placebo. Intravenous administration of iron sucrose in the setting of transient hyperhomocysteinemia induced by methionine ingestion significantly increased transferrin saturation and plasma levels of NTBI and significantly attenuated flow-mediated dilation in the brachial artery when compared with placebo. This potential mechanistic link between intravenous iron and endothelial dysfunction warrants further study of cardiovascular effects of intravenous iron in anemic chronic kidney disease populations.

Overview

Integrity signals

Registry

Crossref · 10.1038/sj.ki.5000046

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Cited by

See all 44

Metadata

Authors
Zheng, H., Huang, X., Zhang, Q., & Katz, S. D.
Affiliations
  • Yale University (US)
  • New York University (US)
Corresponding author
Katz, S.D.
Venue
Kidney International
Publisher
Elsevier BV
Published
2006-02
Volume
69
Issue
4
Pages
679-684
ISSN
0085-2538 (ISSN-L)
OpenAlex
W2067573387
Cited by
44
References
64
Citations by year
2026: 2 · 2025: 3 · 2024: 2 · 2021: 3 · 2020: 3 · 2019: 2 · 2018: 1 · 2017: 1 · 2016: 2 · 2015: 3 · 2014: 2 · 2013: 2 · 2012: 3
FWCI
1.82
Type
journal article
Language
en
Open access
Licence
Locations
  • Kidney International (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Amgen
  • Yale University
  • National Center for Research Resources ((5 MO1 RR00645, M01RR000645)
  • NIH Clinical Center
Topics
  • Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
  • Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
Keywords
iron sucrose, endothelial dysfunction, homocysteine, hyperhomocysteinemia, flow-mediated dilation, non-transferrin-bound iron, transferrin saturation, nitrotyrosine, oxidative stress, brachial artery, intravenous iron, anemia of chronic kidney disease, cardiovascular risk
MeSH terms
Ferric Oxide, Saccharated, Adult, Brachial Artery, Cardiovascular Diseases, Chelating Agents, Double-Blind Method, Endothelium, Vascular, Female, Ferric Compounds, Ferritins, Glucaric Acid, Nitroglycerin, Homocysteine, Humans, Iron, Male, Methionine, Razoxane, Regional Blood Flow, Risk Factors, Transferrin, Tyrosine, Vasodilation, Oxidative Stress, Anemia, Iron-Deficiency

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.